<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02597491</url>
  </required_header>
  <id_info>
    <org_study_id>2015NTLS048</org_study_id>
    <nct_id>NCT02597491</nct_id>
  </id_info>
  <brief_title>Program on Lung Cancer Screening and Tobacco Cessation</brief_title>
  <acronym>PLUTO</acronym>
  <official_title>Adaptive Interventions for Smoking Cessation in Lung Cancer Screening Programs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this sequential, multiple assignment, randomized trial (SMART) current smokers who are&#xD;
      eligible for lung cancer screening will be identified using the electronic medical record at&#xD;
      the University of Minnesota and Minneapolis VA (N=1000). All participants will receive 8&#xD;
      weeks of evidence-based first-line smoking cessation treatment. Participants will be eligible&#xD;
      for three potential randomizations during one year of smoking intervention: 1) to timing of&#xD;
      identifying early response to treatment at 4 vs. 8 weeks (all participants), 2) to&#xD;
      telephone-based tobacco longitudinal care (TLC) vs. TLC plus pharmacist-administered&#xD;
      Medication Therapy Management (incomplete responders to first-line treatment, Primary Aim),&#xD;
      and 3) to monthly TLC contact vs. quarterly TLC contact (complete responders to first-line&#xD;
      treatment, Secondary Aim). The primary outcome will be 6 months of prolonged abstinence&#xD;
      measured 18 months after the beginning of treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this sequential, multiple assignment, randomized trial (SMART) current smokers who are&#xD;
      eligible for lung cancer screening will be identified using the electronic medical record at&#xD;
      the University of Minnesota and Minneapolis VA (N=1000). All participants will receive 8&#xD;
      weeks of evidence-based first-line smoking cessation treatment. Participants will be eligible&#xD;
      for three potential randomizations during one year of smoking intervention: 1) to timing of&#xD;
      identifying early response to treatment at 4 vs. 8 weeks (all participants), 2) to&#xD;
      telephone-based tobacco longitudinal care (TLC) vs. TLC plus pharmacist-administered&#xD;
      Medication Therapy Management (incomplete responders to first-line treatment, Primary Aim),&#xD;
      and 3) to monthly TLC contact vs. quarterly TLC contact (complete responders to first-line&#xD;
      treatment, Secondary Aim). The primary outcome will be 6 months of prolonged abstinence&#xD;
      measured 18 months after the beginning of treatment (self-reported smoking abstinence using&#xD;
      imputation for missing data).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">August 30, 2021</completion_date>
  <primary_completion_date type="Actual">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>6 months prolonged abstinence from smoking, measured 18M after randomization</measure>
    <time_frame>18 months</time_frame>
    <description>The primary (dichotomous) outcome for all analyses will be whether or not smokers achieve 6-month prolonged abstinence measured at 18 months after the baseline assessment. All analyses will be by intention-to-treat, and include all participants randomized to intervention, regardless of whether they are lost to follow-up.</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Smoking</condition>
  <arm_group>
    <arm_group_label>4 wk assessment + TLC monthly</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>4 week assessment, 8 weeks of counseling, NRT, monthly follow-up (responders)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4 week assessment + TLC quarterly</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>4 week assessment, 8 weeks of counseling, NRT, quarterly follow-up (responders)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4 week assessment +TLC + MTM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>4 week assessment, 4 weeks counseling, NRT, medication management (nonresponders)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8 week assessment + TLC monthly</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>8 week assessment, 8 weeks of counseling, NRT, monthly follow-up (responders)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8 week assessment + TLC quarterly</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>8 week assessment, 8 weeks of counseling, NRT, quarterly follow-up (responders)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8 week assessment + TLC + MTM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>8 week assessment, 8 weeks counseling, NRT, medication management (nonresponders)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>TLC monthly</intervention_name>
    <description>Tobacco longitudinal care monthly</description>
    <arm_group_label>4 week assessment +TLC + MTM</arm_group_label>
    <arm_group_label>4 wk assessment + TLC monthly</arm_group_label>
    <arm_group_label>8 week assessment + TLC + MTM</arm_group_label>
    <arm_group_label>8 week assessment + TLC monthly</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>TLC quarterly</intervention_name>
    <description>Tobacco longitudinal care quarterly</description>
    <arm_group_label>4 week assessment + TLC quarterly</arm_group_label>
    <arm_group_label>8 week assessment + TLC quarterly</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>MTM</intervention_name>
    <description>Medication management therapy</description>
    <arm_group_label>4 week assessment +TLC + MTM</arm_group_label>
    <arm_group_label>8 week assessment + TLC + MTM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>4 week assessment</intervention_name>
    <description>4 week assessment</description>
    <arm_group_label>4 week assessment + TLC quarterly</arm_group_label>
    <arm_group_label>4 week assessment +TLC + MTM</arm_group_label>
    <arm_group_label>4 wk assessment + TLC monthly</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>8 week assessment</intervention_name>
    <description>8 week assessment</description>
    <arm_group_label>8 week assessment + TLC + MTM</arm_group_label>
    <arm_group_label>8 week assessment + TLC monthly</arm_group_label>
    <arm_group_label>8 week assessment + TLC quarterly</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. scheduled or has order for low dose CT screening for lung cancer, or is eligible for&#xD;
             screening low-dose CT&#xD;
&#xD;
          2. current daily smoker (eligible smokers will have smoked during the past 30 days and on&#xD;
             at least 5 out of the past 7 days; individuals who have made a recent quit attempt,&#xD;
             for example, in anticipation of their low dose CT scan for lung cancer screening, will&#xD;
             be eligible if during the last 30 days, when they were smoking regularly, they smoked&#xD;
             on at least 5 out of 7 days of the week).&#xD;
&#xD;
          3. 55 to 79 years old,&#xD;
&#xD;
          4. Interested in quitting and willing to choose a quit smoking date within the next 12&#xD;
             weeks,&#xD;
&#xD;
          5. voluntary written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Unstable psychiatric disease, unless stable in treatment for 3 months (smokers on&#xD;
             mental health medication with any changes in medication in past 3 months require study&#xD;
             MD approval to participate) - Smokers with stable psychiatric disease will be&#xD;
             eligible; this baseline characteristic and related symptoms will be considered in&#xD;
             analyses,&#xD;
&#xD;
          2. No hospitalization for mental health reasons in past 3 months; No thoughts of&#xD;
             self-harm in past 2 weeks,&#xD;
&#xD;
          3. No recent cognitive impairment (difficulties planning or organizing daily activities,&#xD;
             such as managing finances, having trouble remembering appointments, or forgetting the&#xD;
             correct month of the year); participants reporting recent cognitive impairment will be&#xD;
             given the 6-item Callahan Cognitive Screener and must score at least a 5 out of 6 to&#xD;
             participate,&#xD;
&#xD;
          4. Participating in a formal quit program (such as tobacco cessation counseling with or&#xD;
             without use of NRT, bupropion, or varenicline; Smokers using NRT will be eligible as&#xD;
             long as they are not using it as part of a formal quit program),&#xD;
&#xD;
          5. No phone&#xD;
&#xD;
          6. Non-English speaking&#xD;
&#xD;
          7. Current diagnosis of lung cancer&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne Joseph, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota</affiliation>
  </overall_official>
  <reference>
    <citation>Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003 Feb;5(1):13-25. Erratum in: Nicotine Tob Res. 2003 Aug;5(4):603.</citation>
    <PMID>12745503</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 28, 2015</study_first_submitted>
  <study_first_submitted_qc>November 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 5, 2015</study_first_posted>
  <last_update_submitted>August 5, 2021</last_update_submitted>
  <last_update_submitted_qc>August 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Smoking,</keyword>
  <keyword>Smoking cessation</keyword>
  <keyword>Sequential, multiple assignment, randomized trials (SMART)</keyword>
  <keyword>Lung cancer screening</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 29, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/91/NCT02597491/SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

